JP2020174615A - Composition for improving brain function - Google Patents

Composition for improving brain function Download PDF

Info

Publication number
JP2020174615A
JP2020174615A JP2019080856A JP2019080856A JP2020174615A JP 2020174615 A JP2020174615 A JP 2020174615A JP 2019080856 A JP2019080856 A JP 2019080856A JP 2019080856 A JP2019080856 A JP 2019080856A JP 2020174615 A JP2020174615 A JP 2020174615A
Authority
JP
Japan
Prior art keywords
rice bran
thermolysin
brain function
composition
improving brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019080856A
Other languages
Japanese (ja)
Inventor
尚久 正箱
Naohisa Masahako
尚久 正箱
耕作 大日向
Kosaku Ohinata
耕作 大日向
雄太郎 小川
Yutaro Ogawa
雄太郎 小川
草刈 剛
Takeshi Kusakari
剛 草刈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP2019080856A priority Critical patent/JP2020174615A/en
Publication of JP2020174615A publication Critical patent/JP2020174615A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

To provide a composition for improving brain function having excellent improving effect of a brain function.SOLUTION: A composition for improving brain function includes a thermolysin processed product of rice bran. The thermolysin processed product may include at least one kind selected from sequence number 1 and Leu-Arg-Ala. The thermolysin processed product is a product obtained by processing compression-defatted rice bran by thermolysin, and may be a water-soluble fraction. The brain function improvement may be cognitive function improvement.SELECTED DRAWING: None

Description

本発明は、米糠由来の成分を含有する脳機能改善用組成物に関する。 The present invention relates to a composition for improving brain function containing a component derived from rice bran.

一般に、米糠は、玄米を精米する過程で得られる果皮、種皮、胚芽等が集合した組成物であり、古くから米糠油の原料、糠漬けの糠床等として用いられてきた。また、米糠には、抗腫瘍作用、抗酸化作用等を有するフィチン酸及びフェルラ酸、コレステロールの吸収抑制作用、更年期障害改善作用、紫外線吸収作用等を有するγ−オリザノール等の有用な成分が含まれていることが知られている。したがって、従来より米糠は、栄養価の高い健康食品の他、医薬品、化粧料等の原料にも用いられてきた。 In general, rice bran is a composition in which pericarp, seed coat, germ, etc. obtained in the process of milling brown rice are aggregated, and has been used as a raw material for rice bran oil, a bran bed pickled in bran, and the like for a long time. In addition, rice bran contains useful components such as phytic acid and ferulic acid having antitumor action, antioxidant action, etc., cholesterol absorption inhibitory action, menopausal disorder improving action, ultraviolet absorption action, etc. It is known that Therefore, rice bran has conventionally been used as a raw material for pharmaceuticals, cosmetics, etc., in addition to highly nutritious health foods.

また、近年、例えば特許文献1,2に開示されるように、米糠に特定のプロテアーゼを作用させることにより、ACE阻害活性等の生体に有用な作用の向上効果が見出されるようになった。 Further, in recent years, as disclosed in Patent Documents 1 and 2, for example, by allowing a specific protease to act on rice bran, an effect of improving an action useful for a living body such as an ACE inhibitory activity has been found.

特許第6296722号公報Japanese Patent No. 6296722 特許第6462100号公報Japanese Patent No. 6462100

本発明の目的とするところは、脳機能の改善作用に優れる脳機能改善用組成物を提供することにある。 An object of the present invention is to provide a composition for improving brain function, which is excellent in improving brain function.

本発明者らは、前記の課題を解決するべく研究した結果、米糠のサーモリシン処理物が優れた脳機能の改善作用を発揮することを見出したことに基づく発明である。
上記目的を達成するために、本発明の一態様は、米糠のサーモリシン処理物を含むことを特徴とする。
As a result of research to solve the above-mentioned problems, the present inventors have found that a thermolysin-treated product of rice bran exerts an excellent effect of improving brain function.
In order to achieve the above object, one aspect of the present invention is characterized by containing a thermolysin-treated product of rice bran.

前記サーモリシン処理物は、配列番号1及びLeu−Arg−Alaから選ばれる少なくとも一種を含んでもよい。前記サーモリシン処理物は、圧搾脱脂米糠をサーモリシン処理したものであって、水溶性画分であってもよい。前記脳機能改善は、認知機能改善であってもよい。 The thermolysin-treated product may contain at least one selected from SEQ ID NO: 1 and Leu-Arg-Ala. The thermolysin-treated product is a thermolysin-treated pressed defatted rice bran and may be a water-soluble fraction. The brain function improvement may be a cognitive function improvement.

本発明の別の態様は、前記脳機能改善用組成物を含む飲食品、医薬品、又は医薬部外品を特徴とする。 Another aspect of the present invention is characterized by a food or drink, a drug, or a quasi-drug containing the composition for improving brain function.

本発明によれば、優れた脳機能改善作用を発揮できる。 According to the present invention, an excellent brain function improving effect can be exhibited.

第1試験グループ(米糠サーモリシン処理物+高脂肪食)の個体群の新規物体探索割合(%)を示すグラフ。The graph which shows the new object search rate (%) of the population of the 1st test group (rice bran thermolysin processed product + high fat diet). 第2試験グループ(圧搾脱脂米糠(ハイブレフ)+高脂肪食)の個体群の新規物体探索割合(%)を示すグラフ。The graph which shows the new object search rate (%) of the population of the 2nd test group (squeezed defatted rice bran (high-fat) + high-fat diet).

以下、本発明の脳機能改善用組成物を具体化した一実施形態を説明する。本実施形態の脳機能改善用組成物に含まれる米糠のサーモリシン処理物の原料に用いられる米糠は、特に限定されないが、例えば米糠そのものであってもよく、脱脂米糠が適用されてもよい。脱脂米糠としては、例えば圧搾により脱脂された圧搾脱脂米糠、有機溶媒を用いて抽出処理された抽出脱脂米糠等が挙げられる。これらの原料の中で圧搾脱脂米糠が好ましい。圧搾脱脂米糠の製造方法としては、例えばまず搗精後に得られた米糠(生米糠)を加熱することでリパーゼを失活させ(リパーゼ失活処理)、さらに圧搾処理する方法が挙げられる。 Hereinafter, an embodiment embodying the composition for improving brain function of the present invention will be described. The rice bran used as a raw material for the thermolysin-treated rice bran contained in the composition for improving brain function of the present embodiment is not particularly limited, but may be, for example, rice bran itself or defatted rice bran may be applied. Examples of the defatted rice bran include defatted defatted rice bran degreased by squeezing, extracted defatted rice bran extracted using an organic solvent, and the like. Among these raw materials, pressed defatted rice bran is preferable. Examples of the method for producing squeezed defatted rice bran include a method in which lipase is inactivated by first heating the rice bran (raw rice bran) obtained after polishing (lipase inactivation treatment), and then squeezed.

リパーゼ失活処理は、18〜20質量%程度の脂質を含有する米糠(生米糠)の酸化劣化を防ぐ目的で行われる。通常、生米糠を70〜130℃程度で加熱焙煎することにより行われる。圧搾処理は、公知の圧搾法、例えば加熱焙煎処理され100〜115℃程度になった米糠を低温連続圧搾機(例えばテクノシグマ社製の商品名:ミラクルチャンバー)により圧搾する方法を適用できる。圧搾は、圧搾後の脱脂米糠中の脂質が5〜20質量%程度となるまで行うことが好ましい。また、リパーゼ失活処理前の米糠や搾油後の脱脂米糠の水分含量を低減させる等の目的で乾燥処理を行ってもよい。更に、特に圧搾脱脂米糠は、公知の方法により粉砕、分級し、粉末状とすることが好ましい。この際、粉末の平均粒子径は、5〜200μmが好ましく、10〜150μmがより好ましく、40〜100μmが最も好ましい。平均粒子径は、篩法により測定できる。なお、脱脂米糠中の脂質含量は、特に限定されないが、5〜20質量%が好ましく、7〜15質量%がより好ましい。なお、脱脂米糠は、市販品を使用してもよい。市販品としては、例えば商品名ハイブレフ(サンブラン社製)等が挙げられる。 The lipase inactivation treatment is carried out for the purpose of preventing oxidative deterioration of rice bran (raw rice bran) containing about 18 to 20% by mass of lipid. Usually, it is carried out by heating and roasting raw rice bran at about 70 to 130 ° C. As the squeezing treatment, a known squeezing method, for example, a method of squeezing rice bran that has been heat-roasted to about 100 to 115 ° C. with a low-temperature continuous squeezing machine (for example, trade name: Miracle Chamber manufactured by TechnoSigma) can be applied. The pressing is preferably performed until the lipid content in the defatted rice bran after pressing is about 5 to 20% by mass. Further, the drying treatment may be carried out for the purpose of reducing the water content of the rice bran before the lipase deactivation treatment and the defatted rice bran after the oil extraction. Further, it is particularly preferable that the pressed defatted rice bran is pulverized and classified by a known method to form a powder. At this time, the average particle size of the powder is preferably 5 to 200 μm, more preferably 10 to 150 μm, and most preferably 40 to 100 μm. The average particle size can be measured by the sieving method. The lipid content in the defatted rice bran is not particularly limited, but is preferably 5 to 20% by mass, more preferably 7 to 15% by mass. As the defatted rice bran, a commercially available product may be used. Examples of commercially available products include the trade name Hi-Bleff (manufactured by Saint-Blanc).

サーモリシンは、バチルス・サーモプロテオライティクス由来の中性金属プロテアーゼであり、EC番号は3.4.24.27である。サーモリシンは、上記微生物より抽出精製したものを使用してもよく、生化学的に合成したものを使用してもよく、また、市販品を使用してもよい。市販品としては、例えばペプチド研究所社製、和光純薬工業社製等が挙げられる。 Thermolysin is a neutral metalloproteinase derived from Bacillus thermoproteolitics and has an EC number of 3.4.24.27. As the thermolysin, one extracted and purified from the above-mentioned microorganism may be used, one biochemically synthesized may be used, or a commercially available product may be used. Examples of commercially available products include those manufactured by Peptide Institute, Ltd., Wako Pure Chemical Industries, Ltd., and the like.

サーモリシン処理物を得るための処理条件としては、サーモリシンの活性が得られる条件であれば、特に制限はされず、例えば温度、pH、時間等の諸条件を適宜設定できる。処理方法としては、例えば米糠原料に溶液として水を加え、必要によりpH調整を行った後、所定量のサーモリシンが添加される。サーモリシンの添加量は、処理条件、原料との比率、酵素の力価等を考慮し、適宜設定できる。サーモリシン処理時の米糠原料は、米糠原料としての米糠又は脱脂米糠をそのまま適用してもよく、米糠原料の水抽出物(水溶性画分)を適用してもよい。米糠原料の水抽出物は、米糠原料を水で抽出処理して得られた液体組成物(水及び抽出された米糠成分からなる)である。水抽出条件は、特に制限されないが、例えば10〜50℃程度の水に米糠原料を1〜24時間程度浸漬(又は撹拌)する方法が例示される。 The treatment conditions for obtaining the thermolysin-treated product are not particularly limited as long as the thermolysin activity can be obtained, and various conditions such as temperature, pH, and time can be appropriately set. As a treatment method, for example, water is added as a solution to the rice bran raw material, the pH is adjusted if necessary, and then a predetermined amount of thermolysin is added. The amount of thermolysin added can be appropriately set in consideration of the treatment conditions, the ratio with the raw material, the titer of the enzyme, and the like. As the rice bran raw material during the thermolysin treatment, rice bran or defatted rice bran as the rice bran raw material may be applied as it is, or a water extract (water-soluble fraction) of the rice bran raw material may be applied. The water extract of the rice bran raw material is a liquid composition (composed of water and the extracted rice bran component) obtained by extracting the rice bran raw material with water. The water extraction conditions are not particularly limited, and examples thereof include a method of immersing (or stirring) the rice bran raw material in water at about 10 to 50 ° C. for about 1 to 24 hours.

サーモリシンの処理条件としては、例えば米糠原料及びサーモリシンを水に混合したうえ、37℃前後で穏やかに撹拌しながら10〜30時間程度反応させることで処理を行うことができる。当該処理後、サーモリシンを失活させてもよい。サーモリシンの失活処理は、例えば加熱(例えば100℃、10〜20分程度の処理)等により行うことができる。 As the treatment conditions for thermolysin, for example, rice bran raw material and thermolysin can be mixed with water and then reacted at about 37 ° C. with gentle stirring for about 10 to 30 hours. After the treatment, the thermolysin may be inactivated. The deactivation treatment of thermolysin can be performed, for example, by heating (for example, treatment at 100 ° C. for about 10 to 20 minutes).

サーモリシン処理物は、上述したように米糠をサーモリシンにより処理して得られた組成物であり、サーモリシンにより低分子化した米糠由来のタンパク質の分解物(特にペプチド)を含む組成物である。かかるペプチドとしては、約10kDa以下のものが含まれることが好ましい。より具体的には、配列番号1(Val−Tyr−Thr−Pro−Gly)及びLeu−Arg−Alaから選ばれる少なくとも一種を含むことがより好ましい。 The thermolysin-treated product is a composition obtained by treating rice bran with thermolysin as described above, and is a composition containing a degradation product (particularly a peptide) of a protein derived from rice bran whose molecular weight is reduced by thermolysin. Such peptides preferably include those of about 10 kDa or less. More specifically, it more preferably contains at least one selected from SEQ ID NO: 1 (Val-Tyr-Thr-Pro-Gly) and Leu-Arg-Ala.

なお、サーモリシン処理後の処理液について、油分が含まれる場合には、さらに米糠タンパク質分解物が含まれる水溶性画分を取り出すことが好ましい。かかる水溶性画分には脳機能改善作用を発揮する成分が含まれている。水溶性画分は、サーモリシン処理後の処理液を例えば遠心分離することにより得られる。また、サーモリシン処理後の処理液は、濾過を行って不溶性画分を除いた濾液として回収することが好ましい。 When the treatment liquid after the thermolysin treatment contains oil, it is preferable to take out a water-soluble fraction further containing a rice bran proteolytic product. Such a water-soluble fraction contains a component that exerts a brain function improving effect. The water-soluble fraction can be obtained by, for example, centrifuging the treatment liquid after the thermolysin treatment. Further, it is preferable that the treatment liquid after the thermolysin treatment is collected as a filtrate from which the insoluble fraction has been removed by filtration.

米糠のサーモリシン処理物の使用形態としては、特に限定されず、上記のように得られた処理液を液状の形態で脳機能改善用組成物としてそのまま適用してもよく、蒸留等により濃縮した濃縮液として適用してもよく、凍結乾燥等により乾燥させて固形物の形態で適用してもよい。 The form of use of the thermolysin-treated product of rice bran is not particularly limited, and the treatment solution obtained as described above may be applied as it is as a composition for improving brain function in a liquid form, and concentrated by distillation or the like. It may be applied as a liquid, or it may be dried by freeze-drying or the like and applied in the form of a solid substance.

米糠のサーモリシン処理物を含む脳機能改善用組成物は、特に経口摂取により優れた脳機能改善作用を発揮する。本実施形態の脳機能改善用組成物は、脳機能障害、特に記憶障害、注意障害、遂行機能障害、社会的行動障害等の認知障害改善のために適用される。具体的には、認知障害を発症する認知症の治療、改善、予防のために用いられる。 The composition for improving brain function containing a thermolysin-treated product of rice bran exerts an excellent effect of improving brain function, especially when taken orally. The composition for improving brain function of the present embodiment is applied for improving cognitive disorders such as brain dysfunction, particularly memory disorder, attention disorder, executive dysfunction, and social behavior disorder. Specifically, it is used for the treatment, improvement, and prevention of dementia that develops cognitive impairment.

認知症としては、具体的にアルツハイマー型認知症、血管性認知症、レビー小体型認知症、前頭側頭型認知症、アルコール性認知症等が挙げられる。認知症の改善とは、上述した記憶障害、注意障害、遂行機能障害、社会的行動障害等の認知症の中核症状の改善の他、妄想、抑うつ、徘徊、不眠、幻覚、意欲の低下等の周辺症状の改善も含まれる。 Specific examples of dementia include Alzheimer's disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia, and alcohol-related dementia. Improvement of dementia includes improvement of core symptoms of dementia such as memory disorder, attention disorder, executive dysfunction, and social behavior disorder, as well as delusion, depression, wandering, insomnia, hallucination, and decreased motivation. It also includes improvement of peripheral symptoms.

脳機能改善用組成物の適用形態としては、特に限定されず、例えば飲食品、医薬品、医薬部外品として適用される。米糠のサーモリシン処理物は、そのまま飲食品又は医薬品素材として用いてもよいし、薬学上又は食品衛生学上許容される担体、添加物等を適宜配合したうえで、製品としてもよい。 The application form of the composition for improving brain function is not particularly limited, and is applied as, for example, food and drink, pharmaceuticals, and quasi-drugs. The thermolysin-treated product of rice bran may be used as it is as a food or drink or a pharmaceutical material, or may be used as a product after appropriately blending a carrier, an additive or the like that is acceptable in terms of pharmacy or food hygiene.

本実施形態の脳機能改善用組成物を、食品、飲料等の飲食品に適用する場合、例えば食品添加用組成物、各種菓子類、ガム類、錠剤、カプセル(ソフトカプセル、ハードカプセル)、各種加工食品、各種飲料等に適用できる。形態としては、適用する素材に応じて適宜設計することができ、例えば粉末状、顆粒状等の固体状、ペースト状、液状等として構成できる。 When the composition for improving brain function of the present embodiment is applied to foods and drinks such as foods and beverages, for example, food additive compositions, various confectioneries, gums, tablets, capsules (soft capsules, hard capsules), various processed foods. , Applicable to various beverages, etc. The form can be appropriately designed according to the material to be applied, and can be configured as, for example, a solid state such as powder or granule, a paste, or a liquid.

飲食品の用途としては、特に限定されず、いわゆる一般食品、健康食品、機能性食品、栄養補助食品、サプリメント、病者用食品、特定用途食品、保健機能食品、栄養機能食品、特定保健用食品、機能性表示食品等として適用できる。飲食品において用途の表示を付す場合、各種法律、施行規則、ガイドライン等によって定められた表示が挙げられる。飲食品において用途の表示には、包装、容器等のパッケージへの表示の他、パンフレット等の広告媒体への表示も含まれる。 The uses of foods and drinks are not particularly limited, and are so-called general foods, health foods, functional foods, nutritional supplements, supplements, foods for the sick, special-purpose foods, health functional foods, nutritional functional foods, and specified health foods. , Applicable as foods with functional claims. When labeling food and drinks for use, the labeling specified by various laws, enforcement regulations, guidelines, etc. can be mentioned. In food and drink, the indication of use includes not only the indication on packages such as packaging and containers, but also the indication on advertising media such as pamphlets.

本実施形態の脳機能改善用組成物の用途の表示内容としては、脳機能改善又は予防の表示の他、上述した中核症状及び周辺症状の改善又は予防の表示が挙げられる。また、これらの改善又は予防を示唆する表示も含まれる。例えば、認知機能の一部である記憶力、注意力、判断力、空間認識力を維持、サポート、又は向上等の表示が挙げられる。さらに具体的には、言葉、数、図形、色、位置情報、顔等の見聞きした物事の情報の記憶し、思い出す力(記憶力)を維持又はサポート、情報の記憶を助ける又は精度の向上、短期記憶(短時間で情報を保持し、同時に処理する能力)を維持又はサポート、注意力(事務作業の速度と正確さ)の維持、計算作業の効率維持等の表現が挙げられる。 In addition to the indication of improvement or prevention of brain function, the indication of the use of the composition for improving brain function of the present embodiment includes the indication of improvement or prevention of the above-mentioned core symptom and peripheral symptom. It also includes labeling suggesting these improvements or preventions. For example, display such as maintenance, support, or improvement of memory, attention, judgment, and spatial cognition, which are part of cognitive function. More specifically, it memorizes information about things that you see and hear, such as words, numbers, figures, colors, position information, and faces, and maintains or supports the ability to remember (memory), helps memorize information, or improves accuracy, short-term. Expressions such as maintaining or supporting memory (ability to retain information in a short time and process it at the same time), maintaining attention (speed and accuracy of office work), and maintaining efficiency of calculation work can be mentioned.

本実施形態の脳機能改善用組成物を、医薬品又は医薬部外品として使用する場合は、服用(経口摂取)により投与する場合の他、経腸投与等を採用することが可能である。剤形としては、特に限定されないが、例えば散剤、粉剤、顆粒剤、錠剤、カプセル剤、丸剤、坐剤、液剤等として構成してもよい。また、添加物として賦形剤、基剤、乳化剤、溶剤、安定剤等を配合してもよい。 When the composition for improving brain function of the present embodiment is used as a drug or a quasi-drug, it can be administered by ingestion (oral ingestion) or enteral administration. The dosage form is not particularly limited, but may be configured as, for example, powder, powder, granule, tablet, capsule, pill, suppository, liquid or the like. Further, excipients, bases, emulsifiers, solvents, stabilizers and the like may be blended as additives.

本実施形態の脳機能改善用組成物の効果について説明する。
(1)本実施形態では、米糠のサーモリシン処理物を含むよう構成した。したがって、優れた脳機能の改善作用を発揮できる。特に認知機能の改善に優れた効果を発揮する。さらには、高脂肪食等の生活習慣由来の認知機能の低下においては、短期間の摂取で認知機能の回復に寄与できる。
The effect of the composition for improving brain function of the present embodiment will be described.
(1) In the present embodiment, it is configured to contain a thermolysin-treated product of rice bran. Therefore, it can exert an excellent effect of improving brain function. In particular, it has an excellent effect on improving cognitive function. Furthermore, in the case of a decline in cognitive function due to lifestyle habits such as a high-fat diet, short-term intake can contribute to the recovery of cognitive function.

なお、上記実施形態は以下のように変更してもよい。
・上記実施形態の脳機能改善用組成物は、脳機能に関する症状の改善を目的として患者への適用のみならず、症状の悪化の防止、症状の低下の遅延、健常者が脳機能の低下の予防を目的とした摂取も含むものとする。また、ヒト以外の飼養動物に適用してもよい。
The above embodiment may be changed as follows.
-The composition for improving brain function of the above-described embodiment is not only applied to patients for the purpose of improving symptoms related to brain function, but also prevents deterioration of symptoms, delays deterioration of symptoms, and causes deterioration of brain function in healthy subjects. It shall also include ingestion for the purpose of prevention. It may also be applied to domestic animals other than humans.

・上記実施形態の脳機能改善用組成物において、医薬品、医薬部外品、又は飲食品に含まれる米糠のサーモリシン処理物の量は、本発明の効果が得られる限り特に制限されず、固形分中において例えば0.1〜100質量%、好ましくは1〜90質量%含むよう構成できる。また、一日の摂取量、摂取期間も目的・容態等に応じて適宜設定できる。 -In the composition for improving brain function of the above embodiment, the amount of the thermolysin-treated rice bran contained in the drug, quasi-drug, or food or drink is not particularly limited as long as the effect of the present invention can be obtained, and the solid content. It can be configured to contain, for example, 0.1 to 100% by mass, preferably 1 to 90% by mass. In addition, the daily intake and the intake period can be appropriately set according to the purpose, condition, and the like.

・上記実施形態の脳機能改善用組成物に配合した米糠のサーモリシン処理物中において、圧搾脱脂米糠を原料して調製した場合、米糠原料中の油性成分であるγ−オリザノールは、例えば50mg/100g(固形分)以下、好ましくは25mg/100g(固形分)以下、フェルラ酸は、例えば100mg/100g(固形分)以下に調製されてもよい。 When prepared from pressed defatted rice bran as a raw material in the thermolysin-treated rice bran blended in the composition for improving brain function of the above embodiment, γ-oryzanol, which is an oily component in the rice bran raw material, is, for example, 50 mg / 100 g. Ferulic acid may be prepared to be (solid content) or less, preferably 25 mg / 100 g (solid content) or less, and ferulic acid, for example, 100 mg / 100 g (solid content) or less.

以下に試験例を挙げ、前記実施形態をさらに具体的に説明するが、本発明はこれらに限定されるものではない。
(米糠のサーモリシン処理物の調製)
原料米糠としては、サンブラン社製の商品名ハイブレフを用いた。ハイブレフは、米糠を圧搾することより脱脂を行った圧搾脱脂米糠である。また、サーモリシンは、ペプチド研究所社製のもの(Code3504)を用いた。
The embodiment will be described in more detail with reference to test examples below, but the present invention is not limited thereto.
(Preparation of thermolysin-treated rice bran)
As the raw material rice bran, the trade name Hibref manufactured by Saint-Blanc was used. Hybref is a squeezed defatted rice bran that has been defatted by squeezing the rice bran. As the thermolysin, one manufactured by Peptide Institute (Code3504) was used.

まず、超純水に米糠原料を30g/Lとなるように混合し、これにサーモリシンを0.4g/Lとなるように加えた。そして、当該混合物を37℃インキュベータ内でスターラーを用いて250r.p.m.で攪拌しながら20時間インキュベートしながら酵素処理した。次に、沸騰水浴に浸漬して15分間処理し、酵素を失活させた。その後、15℃、7150r.p.m.(8000×g)で15分遠心分離処理を行い、固液分離を行った。得られた上清のpHをNaOHを用いて7.0に調整し、フィルターペーパーNo.2(アドバンテック社製)を用いて濾過して、得られた濾液を凍結乾燥した。当該凍結乾燥物を、米糠サーモリシン処理物として使用した。なお、米糠サーモリシン処理物中には、限外濾過により約10kDa以下のペプチドが含まれていることを確認している。また、アミノ酸配列分析により、配列番号1及びLeu−Arg−Alaのペプチドが含まれていることを確認している。 First, the rice bran raw material was mixed with ultrapure water so as to be 30 g / L, and thermolysin was added to this so as to be 0.4 g / L. Then, the mixture was enzymatically treated in a 37 ° C. incubator using a stirrer while stirring at 250 r.p.m. for 20 hours. Next, it was immersed in a boiling water bath and treated for 15 minutes to inactivate the enzyme. Then, the mixture was centrifuged at 7150 r.p.m. (8000 × g) for 15 minutes at 15 ° C. to perform solid-liquid separation. The pH of the obtained supernatant was adjusted to 7.0 using NaOH, and the filter paper No. Filtration was carried out using 2 (manufactured by Advantech), and the obtained filtrate was lyophilized. The freeze-dried product was used as a rice bran thermolysin-treated product. It has been confirmed by ultrafiltration that the rice bran thermolysin-treated product contains a peptide of about 10 kDa or less. In addition, it has been confirmed by amino acid sequence analysis that the peptides of SEQ ID NO: 1 and Leu-Arg-Ala are contained.

(認知機能の測定)
試験方法は、マウスの物体認識試験法(Marianne. leger et al., Nature Protocols 8 (12), 2531-2537, 2013)に基づいて行った。
(Measurement of cognitive function)
The test method was based on the mouse object recognition test method (Marianne. Leger et al., Nature Protocols 8 (12), 2531-2537, 2013).

第1試験グループにおいて、通常食(コントロール)、高脂肪食、及び上記米糠サーモリシン処理物を0.4質量%配合した高脂肪食をマウスの各個体群(n=5-8)に1週間それぞれ与えた。また、第2試験グループにおいて、通常食、高脂肪食、及びサーモリシン処理を行っていない圧搾脱脂米糠(ハイブレフ)を0.4質量%配合した高脂肪食をマウスの各個体群(n=5-8)に1週間それぞれ与えた。 In the first test group, a normal diet (control), a high-fat diet, and a high-fat diet containing 0.4% by mass of the above-mentioned rice bran thermolysin-treated product were applied to each mouse population (n = 5-8) for one week. Gave. In addition, in the second test group, each population of mice (n = 5-) was provided with a normal diet, a high-fat diet, and a high-fat diet containing 0.4% by mass of pressed defatted rice bran (high-bluff) not treated with thermolysin. 8) was given for one week respectively.

尚、試験に用いたマウスは、10週齢の雄ddYマウスを使用した。通常食としてはMF飼料(オリエンタルバイオ社製)、高脂肪食としては表1に示される成分からなるHFD-60(オリエンタルバイオ社製)を使用した。米糠成分を配合した高脂肪食としては、表1に示されるようにHFD-60の組成をベースとして調製した。また、高脂肪食に配合した米糠サーモリシン処理物及び圧搾脱脂米糠(ハイブレフ)について、それぞれ総フェルラ酸及びγ−オリザノールの含有量をHPLCを用いて測定した。結果を表2に示す。 As the mouse used in the test, a 10-week-old male ddY mouse was used. As a normal diet, MF feed (manufactured by Orientalbio Co., Ltd.) was used, and as a high-fat diet, HFD-60 (manufactured by Orientalbio Co., Ltd.) consisting of the components shown in Table 1 was used. A high-fat diet containing a rice bran component was prepared based on the composition of HFD-60 as shown in Table 1. In addition, the total ferulic acid and γ-oryzanol contents of the rice bran thermolysin-treated product and the pressed defatted rice bran (Hybref) blended in the high-fat diet were measured by HPLC, respectively. The results are shown in Table 2.

飼育6日目に、各個体群中のマウス1匹を所定の大きさの箱の中に入れ、5分間環境に順応させた(馴化1)。24時間後、2個の物体が左右1箇所ずつ設置された箱の中にマウスを入れ、両方の物体探索時間の合計が20秒になるまで行動させた後にその箱から取り出し、ケージに戻した(馴化2)。この際、箱に入っている物体は2個とも同じもので積み木又はフラスコである。さらに1時間後に2個の物体のうち片方を別の形の物体で置き換えた箱の中にマウスを入れ、両方の探索時間の合計が20秒になるまでマウスを行動させ、そのうち置き換えた新規物体の方の探索時間の割合(%)を求めた。 On the 6th day of breeding, one mouse in each population was placed in a box of a predetermined size and adapted to the environment for 5 minutes (acclimation 1). Twenty-four hours later, the mouse was placed in a box in which two objects were placed one on each side, and after the two objects were allowed to act until the total search time for both objects reached 20 seconds, they were taken out of the box and returned to the cage. (Familiarization 2). At this time, the two objects in the box are the same and are blocks or flasks. One hour later, the mouse was placed in a box in which one of the two objects was replaced with an object of another shape, and the mouse was moved until the total search time of both objects reached 20 seconds. The ratio (%) of the search time for the mouse was calculated.

尚、新規物体が右側にあるか左側にあるかは完全にランダムになるように試験した。試験の箱は、パーテーションで区切られた区画に設置し、試験者は箱の上空に設置したビデオカメラを通じてパーテーション外から行動を観察し、マウスからは見え無いようにした。本試験は、全て12時間の明期及び12時間の暗期周期となるように設定された23℃に設定された施設で行っている。 It should be noted that whether the new object is on the right side or the left side was tested so as to be completely random. The test box was placed in a compartment separated by a partition, and the tester observed the behavior from outside the partition through a video camera placed above the box so that it could not be seen by the mouse. All of this test was conducted in a facility set at 23 ° C., which was set to have a 12-hour light period and a 12-hour dark period.

各試験グループの個体群において平均値±標準偏差を求めた。第1試験グループ(米糠サーモリシン処理物+高脂肪食)の個体群の結果を図1に示す。第2試験グループ(圧搾脱脂米糠(ハイブレフ)+高脂肪食)の個体群の結果を図2に示す。*は、p<0.05(tukey’s多重検定)を示す。 Mean ± standard deviation was calculated for the population of each test group. The results of the population of the first test group (rice bran thermolysin-treated product + high-fat diet) are shown in FIG. The results of the population of the second test group (squeezed defatted rice bran (high-fat) + high-fat diet) are shown in FIG. * Indicates p <0.05 (tukey's multiple test).

図1,2に示されるように、通常食を与えたマウスでは、新規物体の探索時間の割合が多いことが確認される。そして、高脂肪食を与えた場合、新規物体の探索時間の割合が通常食の場合に比べて低下することが確認される。つまり、生活習慣、特に食生活の乱れにより認知機能の低下が生ずることが確認される。かかる認知機能が低下する環境下において、米糠サーモリシン処理物を高脂肪食に添加した個体群においては、有意に新規物体の探索時間の割合の上昇が認められた(図1)。つまり、米糠サーモリシン処理物の摂取により、認知機能の回復が認められた。一方、サーモリシン処理を行っていない圧搾脱脂米糠(ハイブレフ)を高脂肪食に添加した個体群においては、認知機能の回復が認められなかった(図2)。米糠をサーモリシン処理することにより生成する成分が認知機能の回復に寄与していることが示唆された。また、表2に示されるように、米糠サーモリシン処理物は、圧搾脱脂米糠と比べてフェルラ酸及びγ−オリザノールの含有量が著しく少ないため、認知機能の回復はこれら以外の成分の関与が示唆された。 As shown in FIGS. 1 and 2, it is confirmed that the ratio of the search time for new objects is large in the mice fed with a normal diet. Then, it is confirmed that when a high-fat diet is given, the ratio of the search time for new objects is lower than that in the case of a normal diet. In other words, it is confirmed that cognitive function declines due to lifestyle-related disorders, especially dietary habits. In such an environment where cognitive function declined, a significant increase in the search time for new objects was observed in the population in which the rice bran thermolysin-treated product was added to the high-fat diet (Fig. 1). In other words, the recovery of cognitive function was observed by ingestion of the rice bran thermolysin-treated product. On the other hand, no recovery of cognitive function was observed in the population to which the pressed defatted rice bran (Hybref) not treated with thermolysin was added to the high-fat diet (Fig. 2). It was suggested that the components produced by treating rice bran with thermolysin contributed to the recovery of cognitive function. In addition, as shown in Table 2, the rice bran thermolysin-treated product has a significantly lower content of ferulic acid and γ-oryzanol than the pressed defatted rice bran, suggesting the involvement of other components in the recovery of cognitive function. It was.

(処方例)
以下に、米糠サーモリシン処理物を用いた処方例を示す。
<処方例1:錠剤>
米糠サーモリシン処理物:10質量%
賦形剤(結晶セルロース等):90質量%
(合計100質量%)
<処方例2:飲料>
米糠サーモリシン処理物:10質量%
果汁:30質量%
水:60質量%
(合計100質量%)
(Prescription example)
An example of prescription using a rice bran thermolysin-treated product is shown below.
<Prescription example 1: Tablets>
Rice bran thermolysin treated product: 10% by mass
Excipients (crystalline cellulose, etc.): 90% by mass
(100% by mass in total)
<Prescription example 2: Beverage>
Rice bran thermolysin treated product: 10% by mass
Juice: 30% by mass
Water: 60% by mass
(100% by mass in total)

Claims (5)

米糠のサーモリシン処理物を含む脳機能改善用組成物。 A composition for improving brain function containing a thermolysin-treated product of rice bran. 前記サーモリシン処理物は、配列番号1及びLeu−Arg−Alaから選ばれる少なくとも一種を含む請求項1に記載の脳機能改善用組成物。 The composition for improving brain function according to claim 1, wherein the thermolysin-treated product contains at least one selected from SEQ ID NO: 1 and Leu-Arg-Ala. 前記サーモリシン処理物は、圧搾脱脂米糠をサーモリシン処理したものであって、水溶性画分である請求項1又は2に記載の脳機能改善用組成物。 The composition for improving brain function according to claim 1 or 2, wherein the thermolysin-treated product is a thermolysin-treated pressed defatted rice bran and is a water-soluble fraction. 前記脳機能改善は、認知機能改善である請求項1〜3のいずれか一項に記載の脳機能改善用組成物。 The composition for improving brain function according to any one of claims 1 to 3, wherein the improvement of brain function is improvement of cognitive function. 請求項1〜4のいずれか一項に記載の脳機能改善用組成物を含む飲食品、医薬品、又は医薬部外品。 A food or drink, a drug, or a quasi-drug containing the composition for improving brain function according to any one of claims 1 to 4.
JP2019080856A 2019-04-22 2019-04-22 Composition for improving brain function Pending JP2020174615A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019080856A JP2020174615A (en) 2019-04-22 2019-04-22 Composition for improving brain function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019080856A JP2020174615A (en) 2019-04-22 2019-04-22 Composition for improving brain function

Publications (1)

Publication Number Publication Date
JP2020174615A true JP2020174615A (en) 2020-10-29

Family

ID=72935413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019080856A Pending JP2020174615A (en) 2019-04-22 2019-04-22 Composition for improving brain function

Country Status (1)

Country Link
JP (1) JP2020174615A (en)

Similar Documents

Publication Publication Date Title
El Sohaimy Functional foods and nutraceuticals-modern approach to food science
JP5300167B2 (en) Composition for treating mood disorders
JP2013241354A (en) Phosphodiesterase 2 inhibitor
WO2016163245A1 (en) Activator of energy metabolism in muscle cells
JP7281031B2 (en) Composition for ameliorating persistent attention deficit associated with aging
JP2003261456A (en) Brain aging-preventing agent
JP2024138435A (en) Food and drink composition
JP2020019733A (en) Oral composition
JP7467804B2 (en) Composition for improving intestinal flora
JP2020174615A (en) Composition for improving brain function
JP7189393B2 (en) Cognitive function improving agent, cognitive function maintaining agent, hippocampal function improving agent and hippocampal function maintaining agent
JP6791478B2 (en) Angiotensin converting enzyme inhibitor containing urolithins
JP6782381B1 (en) Food composition for improving brain function, brain function improving agent, food composition for increasing brain-derived neurotrophic factor, food composition for suppressing stress hormone secretion, brain-derived neurotrophic factor increasing agent and stress hormone secretion inhibitor
TW586930B (en) Pure 3R-3&#39;R stereoisomer of zeaxanthin for treating macular degeneration in humans
JP2017160134A (en) α-GLUCOSIDASE ACTIVITY INHIBITOR COMPRISING UROLITHINS, AND AGENT FOR INHIBITING INCREASE IN BLOOD GLUCOSE LEVEL COMPRISING UROLITHINS
JP7513390B2 (en) Composition for improving obesity and composition for improving type II diabetes
JP2022007698A (en) Composition for improving brain functions
JP2019180412A (en) Oral composition
JP7430172B2 (en) Composition for increasing the occupancy of Faecalibacterium in the intestinal flora
JP7344722B2 (en) Composition for improving constitutive behavior
JP6964635B2 (en) Orientation composition
JP2019176828A (en) Oral composition
WO2023210679A1 (en) Composition for improving brain function
JP7549933B2 (en) Maintenance Agent
JP2007320947A (en) Agent for suppressing rise in blood sugar level